New blood pressure drug offers hope for treatment-resistant patients

Scientists unveiled baxdrostat, a new pill that reduces dangerously high blood pressure in patients who fail standard treatments. In global trials, the drug lowered blood pressure by nearly 10 mmHg by targeting salt-retention hormones, potentially preventing heart attacks, strokes, and kidney disease in millions of resistant patients.